DIAMETIC-G2 contains Glimepiride 2 mg + Metformin HCl 500 mg SR (Bilayered), a dual-action antidiabetic formulation designed to support effective glycaemic control in Type 2 Diabetes Mellitus. A valuable addition to a PCD Cardiac-Diabetic portfolio.
Type 2 diabetes.
Yes.
No, unless specifically advised.
Monitor blood glucose regularly. Take with meals as directed and remain alert for symptoms of hypoglycemia. Dosage should be individualized by the physician.
Nausea, diarrhea, abdominal discomfort, headache, dizziness and hypoglycemia, particularly with Glimepiride.
DIAMETIC-G2: Glimepiride stimulates pancreatic insulin release, while Metformin reduces hepatic glucose production and improves insulin sensitivity. Together, they provide complementary blood-glucose lowering action.
